etoposide has been researched along with tyrosine in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (25.00) | 18.2507 |
| 2000's | 11 (68.75) | 29.6817 |
| 2010's | 1 (6.25) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hamburger, AW; Mishra, S | 1 |
| Feldhoff, RC; Galperina, OV; Lock, RB; Rhodes, LJ | 1 |
| Albero, D; Bardelli, A; Comoglio, PM; Goruppi, S; Longati, P; Ponzetto, C; Schneider, C | 1 |
| Burden, DA; Kingma, PS; Osheroff, N | 1 |
| Aizu-Yokota, E; Hasegawa, M; Kasahara, T; Momoi, T; Sakurai, S; Sonoda, Y; Yamamoto, D | 1 |
| Eggen, BJ; Kruijer, W; Schuringa, JJ; Vellenga, E; Wierenga, AT | 1 |
| Penzo, D; Pinna, LA; Ruzzene, M | 1 |
| Cotter, TG; Keeshan, K; McKenna, SL | 1 |
| Azuma, K; Fujita, Y; Harigaya, K; Higashi, M; Hiwasa, T; Ishii, G; Kishi, H; Kitagawa, M; Koda, K; Nakajima, N; Nakamura, S | 1 |
| Bhakta, K; Costanzo, A; Puri, PL; Wang, JY; Wood, LD; Zhu, J | 1 |
| Gaedicke, G; Huebener, N; Jikai, J; Lange, B; Lode, HN; Schroeder, U; Shabat, D; Shamis, M; Wenkel, J; Wrasidlo, W | 1 |
| Chang, NS; Doherty, J; Ensign, A; Hong, Q; Hsu, LJ; Schultz, L | 1 |
| Belikova, NA; Jiang, J; Kagan, VE; Kapralov, AA; Kini, V; Kurnikov, IV; Tyurin, VA; Tyurina, YY; Vlasova, II; Yalowich, JC | 1 |
| Ghafourifar, P; Parihar, A; Parihar, MS | 1 |
| Blass, M; Blumberg, PM; Brodie, C; Brody, Y; Finniss, S; Kahana, S; Lee, HK; Lomonaco, SL; Okhrimenko, H; Xiang, C | 1 |
| Aytekin, V; Karabay, KO; Yildiz, O | 1 |
16 other study(ies) available for etoposide and tyrosine
| Article | Year |
|---|---|
O-phospho-L-tyrosine inhibits cellular growth by activating protein tyrosine phosphatases.
Topics: Breast Neoplasms; Carcinoma, Renal Cell; Cell Death; Cell Division; Doxorubicin; Enzyme Activation; Epidermal Growth Factor; ErbB Receptors; Etoposide; Humans; Kidney Neoplasms; Neoplasm Proteins; Phosphorylation; Phosphotyrosine; Protein Tyrosine Phosphatases; S Phase; Sensitivity and Specificity; Tumor Cells, Cultured; Tyrosine | 1993 |
Concentration-dependent differences in the mechanisms by which caffeine potentiates etoposide cytotoxicity in HeLa cells.
Topics: Apoptosis; Caffeine; Cell Death; Dose-Response Relationship, Drug; Drug Synergism; Etoposide; G2 Phase; HeLa Cells; Humans; Phosphorylation; Time Factors; Tyrosine | 1994 |
HGF receptor associates with the anti-apoptotic protein BAG-1 and prevents cell death.
Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; Blotting, Western; Carrier Proteins; Cells, Cultured; Cloning, Molecular; DNA-Binding Proteins; Etoposide; Gene Expression Regulation; Liver; Mice; Mutation; Phosphorylation; Proto-Oncogene Proteins c-met; Receptor Protein-Tyrosine Kinases; Receptors, Platelet-Derived Growth Factor; Staurosporine; Transcription Factors; Transfection; Tyrosine | 1996 |
Binding of etoposide to topoisomerase II in the absence of DNA: decreased affinity as a mechanism of drug resistance.
Topics: Antineoplastic Agents; Binding Sites; Binding, Competitive; DNA; DNA Topoisomerases, Type II; Drug Resistance, Neoplasm; Etoposide; Mutation; Saccharomyces cerevisiae; Tyrosine | 1999 |
FTY720, a novel immunosuppressive agent, induces apoptosis in human glioma cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Caspase 3; Caspase 6; Caspases; Cell Death; Cell Survival; Cysteine Proteinase Inhibitors; DNA Fragmentation; Dose-Response Relationship, Drug; Enzyme Activation; Etoposide; Fingolimod Hydrochloride; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Glioma; Humans; Immunosuppressive Agents; Oligopeptides; Phosphatidylinositol 3-Kinases; Phosphorylation; Propylene Glycols; Protein Serine-Threonine Kinases; Protein Tyrosine Phosphatases; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Sphingosine; Time Factors; Tumor Cells, Cultured; Tyrosine; Vanadates | 2001 |
Downregulation of IL-6-induced STAT3 tyrosine phosphorylation by TGF-beta1 is mediated by caspase-dependent and -independent processes.
Topics: Amino Acid Chloromethyl Ketones; Annexin A5; Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Carrier Proteins; Caspase 3; Caspase Inhibitors; Caspases; Cysteine Proteinase Inhibitors; DNA-Binding Proteins; Down-Regulation; Electrophoretic Mobility Shift Assay; Epithelial Cells; Etoposide; Humans; Interleukin-6; Intracellular Signaling Peptides and Proteins; Janus Kinase 1; Leukemia, Myeloid, Acute; Phosphorylation; Protein Transport; Protein-Tyrosine Kinases; Repressor Proteins; Signal Transduction; Smad3 Protein; STAT3 Transcription Factor; Suppressor of Cytokine Signaling 1 Protein; Suppressor of Cytokine Signaling Proteins; Trans-Activators; Transforming Growth Factor beta; Transforming Growth Factor beta1; Tumor Cells, Cultured; Tyrosine | 2002 |
Protein kinase CK2 inhibitor 4,5,6,7-tetrabromobenzotriazole (TBB) induces apoptosis and caspase-dependent degradation of haematopoietic lineage cell-specific protein 1 (HS1) in Jurkat cells.
Topics: Adaptor Proteins, Signal Transducing; Apoptosis; Blood Proteins; Casein Kinase II; Caspase 3; Caspases; Cell Death; Cell Survival; Cytochrome c Group; DNA Fragmentation; Dose-Response Relationship, Drug; Enzyme Inhibitors; Etoposide; Humans; Jurkat Cells; Phosphorylation; Poly(ADP-ribose) Polymerases; Precipitin Tests; Protein Binding; Protein Serine-Threonine Kinases; Serine; Threonine; Time Factors; Triazoles; Tyrosine | 2002 |
High Bcr-Abl expression prevents the translocation of Bax and Bad to the mitochondrion.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; bcl-Associated Death Protein; bcl-X Protein; Carrier Proteins; Caspase 3; Caspases; Cytoplasm; Drug Resistance, Neoplasm; Enzyme Inhibitors; Etoposide; Fusion Proteins, bcr-abl; Hematopoietic Stem Cells; Humans; Immunoblotting; Interleukin-3; Janus Kinase 2; Membrane Potentials; Mitochondria; Phosphorylation; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Tyrosine | 2002 |
CD44 signaling through focal adhesion kinase and its anti-apoptotic effect.
Topics: Apoptosis; Etoposide; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Humans; Hyaluronan Receptors; Hyaluronic Acid; Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein-Tyrosine Kinases; Recombinant Proteins; rho GTP-Binding Proteins; Signal Transduction; Transfection; Tumor Cells, Cultured; Tyrosine | 2002 |
A myogenic differentiation checkpoint activated by genotoxic stress.
Topics: 3T3 Cells; Animals; Cell Cycle; Cell Differentiation; Cells, Cultured; Cisplatin; DNA Damage; DNA Repair; Etoposide; Methyl Methanesulfonate; Mice; Muscle Fibers, Skeletal; Mutagens; Myoblasts; MyoD Protein; Myogenin; Myosin Heavy Chains; Phosphorylation; Point Mutation; Proto-Oncogene Proteins c-abl; Proto-Oncogene Proteins c-jun; Radiation, Ionizing; Transcriptional Activation; Tumor Suppressor Protein p53; Tyrosine | 2002 |
Neuroblastoma directed therapy by a rational prodrug design of etoposide as a substrate for tyrosine hydroxylase.
Topics: Animals; Antineoplastic Agents, Phytogenic; Biotransformation; Blotting, Western; Cell Survival; Chromatography, High Pressure Liquid; Dihydroxyphenylalanine; Drug Design; Escherichia coli; Etoposide; Humans; Mice; Neuroblastoma; Plasmids; Prodrugs; Substrate Specificity; Tumor Cells, Cultured; Tyrosine; Tyrosine 3-Monooxygenase | 2003 |
WOX1 is essential for tumor necrosis factor-, UV light-, staurosporine-, and p53-mediated cell death, and its tyrosine 33-phosphorylated form binds and stabilizes serine 46-phosphorylated p53.
Topics: Active Transport, Cell Nucleus; Animals; Anisomycin; Cell Line, Tumor; Cell Nucleus; Cytoplasm; Cytosol; DNA, Complementary; Dose-Response Relationship, Drug; Etoposide; Fibroblasts; Genes, Dominant; Humans; Hypoxia; Imidazoles; Immunoprecipitation; Luminescent Proteins; Mice; Microscopy, Fluorescence; Models, Biological; Oxidoreductases; Phosphorylation; Piperazines; Proteasome Endopeptidase Complex; Protein Binding; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Serine; Staurosporine; Time Factors; Tumor Necrosis Factor-alpha; Tumor Suppressor Protein p53; Tumor Suppressor Proteins; Two-Hybrid System Techniques; Tyrosine; U937 Cells; Ultraviolet Rays; WW Domain-Containing Oxidoreductase | 2005 |
Mechanisms of cardiolipin oxidation by cytochrome c: relevance to pro- and antiapoptotic functions of etoposide.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Azo Compounds; Cardiolipins; Cytochromes c; Electron Spin Resonance Spectroscopy; Etoposide; Free Radicals; HL-60 Cells; Humans; Nitriles; Oxidation-Reduction; Peroxides; Tyrosine | 2006 |
Significance of mitochondrial calcium and nitric oxide for apoptosis of human breast cancer cells induced by tamoxifen and etoposide.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Calcium; Cell Line, Tumor; Cytochromes c; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Membrane Potential, Mitochondrial; Mitochondria; Nitric Oxide; Tamoxifen; Time Factors; Tyrosine | 2008 |
Phosphorylation of protein kinase Cdelta on distinct tyrosine residues induces sustained activation of Erk1/2 via down-regulation of MKP-1: role in the apoptotic effect of etoposide.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Dual Specificity Phosphatase 1; Etoposide; Gene Expression Regulation, Enzymologic; Humans; Microscopy, Confocal; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mutagenesis, Site-Directed; Mutation; Phosphorylation; Protein Kinase C-delta; Signal Transduction; Tyrosine | 2008 |
Multiple coronary thrombi with cisplatin.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Coronary Thrombosis; Etoposide; Humans; Male; Percutaneous Coronary Intervention; Stents; Teratoma; Testicular Neoplasms; Tirofiban; Treatment Outcome; Tyrosine | 2014 |